FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/102725 [Registered on: 02/02/2026] Trial Registered Prospectively
Last Modified On: 02/02/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study in children aged 7–12 years to compare Shatpushpa Churna and Saraswat Churna for improving memory 
Scientific Title of Study   COMPARATIVE CLINICAL EVALUATION OF SHATPUSHPA CHURNA AND SARASWAT CHURNA ON MEMORY ENHANCEMENT IN CHILDREN (7–12 YEARS) USING PGI MEMORY SCALE 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shahadat Khan 
Designation  Assistant Professor 
Affiliation  Post Graduate Institute of Ayurveda Jodhpur 
Address  PG Department of Kaumarbhritya Post graduate Institute of Ayurveda Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Campus Kadvad Jodhpur Rajasthan 342037

Jodhpur
RAJASTHAN
342037
India 
Phone  9166109123  
Fax    
Email  Shahadat1991khan@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Harish Kumar Singhal 
Designation  Professor & HOD 
Affiliation  Post Graduate Institute of Ayurveda Jodhpur 
Address  Room no. 155 PG Department of Kaumarbhritya Post graduate Institute of Ayurveda Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Campus Kadvad Jodhpur Rajasthan 342037

Jodhpur
RAJASTHAN
342037
India 
Phone  8619892143  
Fax    
Email  ayurharish14@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Harish Kumar Singhal 
Designation  Professor & HOD 
Affiliation  Post Graduate Institute of Ayurveda Jodhpur 
Address  Room no. 155 PG Department of Kaumarbhritya Post graduate Institute of Ayurveda Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Campus Kadvad Jodhpur Rajasthan 342037

Jodhpur
RAJASTHAN
342037
India 
Phone  8619892143  
Fax    
Email  ayurharish14@gmail.com  
 
Source of Monetary or Material Support  
Post Graduate Institute of Ayurveda Jodhpur Dr Sarvepalli Radhakrishnan Rajsthan Ayurved University Jodhpur Rajasthan INDIA 342037 
 
Primary Sponsor  
Name  Post Graduate Institute of Ayurveda DSRRAU Jodhpur 
Address  PG Department of Kaumarbhritya Post graduate Institute of Ayurveda DSRRAU Jodhpur Rajasthan 342037 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shahadat Khan  Post graduate Institute of Ayurveda DSRRAU Jodhpur   PG Department of Kaumarbhritya Post graduate Institute of Ayurveda Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Campus Kadvad Jodhpur Rajasthan 342037 Jodhpur RAJASTHAN 342037 India
Jodhpur
RAJASTHAN 
9166109123

Shahadat1991khan@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Post Graduate Institute of Ayurved  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  • Children of either sex aged 7–12 years with average or below-average PGI Memory Scale scores 
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Saraswata Churna, Reference: Bhaishjya Ratnawali, Route: Oral, Dosage Form: Churna/ Powder, Dose: 2.5(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 8 Weeks, anupAna/sahapAna: Yes(details: Madhu & Ghrita), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Shatpushpa Churna, Reference: Kashyap Samhita, Route: Oral, Dosage Form: Churna/ Powder, Dose: 2.5(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 8 Weeks, anupAna/sahapAna: Yes(details: Madhu & Ghrita), Additional Information: -
 
Inclusion Criteria  
Age From  7.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  1. Children of either sex aged 7–12 years with average or below average PGI Memory Scale scores.
2. Informed consent from parent or guardians.
 
 
ExclusionCriteria 
Details  1. Children below 7 years and above 12 years.
2. Children with psychiatric disorders, neurological illnesses, or systemic chronic diseases.
3. Children on concurrent nootropic therapy.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in the PGI Memory Score of school going children  8 weeks  
 
Secondary Outcome  
Outcome  TimePoints 
• Improvement in concentration and academic performance.
• Parent and teacher-reported quality of life enhancement.
 
8 weeks 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
  • Study Type: Interventional, randomized, open-label, two-arm comparative study.
  • Control: Comparative, explorative
  • Groups: Two groups (Saraswat vs. Shatpushpa).
  • Research Support: PG Scholars as field investigators and data collectors. 
  • Baseline Assessment: PGI Memory Scale administration, consent forms, academic history.
  • Drug Intervention: 100 children randomized into two groups, drug given for 8 weeks.
  • Follow-up: 4th, 8th & 12th week.
  • Data Entry & Analysis: Using SPSS software.
 
Close